 |
|||||
|
|
|||||
 |
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|
|
|
||||
|
|
|
|
|
||||
December 8-10, 2003, Barcelona Hilton, Barcelona Spain
| 7:45-8:45 AM | Registration & Continental Breakfast |
| 8:45-9:00 AM | Opening Remarks |
| 9:00-9:45 AM | Keynote Address: Uquifa, Inc., "The Industrial Challenge: Europe," Mr. Mark Robbins, Uquifa, Inc. |
| 9:45-10:20 AM | Strategic Developments for Success in Fine Chemicals Manufacture, Dr. Ian Grayson, Degussa Fine Chemicals |
| 10:20-10:55 AM | Practical Process Solutions for Organometal-Catalyzed Reactions, Dr. Atul Kotnis, Bristol Myers Squibb Pharmaceuticals |
| 10:55-11:25 AM | Morning Break - *Sponsored by Degussa* |
| 11:25-12:00 PM | Separation of Enantiomers by Chromatography: A Strategic Methodology in Drug and Fine Chemical Development, Dr. Pilar Franco, Chiral Technologies Europe |
| 12:00-12:35 PM | It's All Gone Racemic - My Son! Dr. Peter Haslam, Uquifa, Inc. |
| 12:35-1:55 PM | Group Luncheon |
| 1:55-2:30 PM | Chiral Technologies - Keys to New Business Growth Dr. Pete Jackson, Avecia Pharmaceutical Products |
| 2:30-3:05 PM | Asymmetric Epoxidations, Dr. Dave Ager, DSM Pharmaceuticals, Inc. |
| 3:05-3:35 PM | Afternoon Break - *Sponsored by Ajinomoto* |
| 3:35-4:10 PM | The Design of New Ligands for Asymmetric Hydrogenation and Hydroformylation Dr. Ian Lennon, Dowpharma |
| 4:10-4:45 PM | High-Speed Experimentation & Simulation in Process R&D, Dr. Goran Verspui, Avantium Technologies BV |
| 4:45-5:45 PM | Special Panel Session: Has Biotechnology Delivered? Mr. Bill Baum, Diversa Corporation Dr. Bernhard Hauer, BASF AG Mr. Nick Hyde, Dowpharma |
| 6:00-7:30 PM | Group Reception - *Sponsored by Uquifa* |
|
|
|||
|
|
|||
|
|
|||